WORCESTER, Mass. – Massachusetts-based Galaxy Life Sciences, in partnership with the Worcester Business Development Corp. (WBDC), has acquired land for the development of a $50 million biomanufacturing facility in the Central Massachusetts city of Worcester. The facility will be situated on six acres within The Reactory, a 46-acre life sciences campus that is a redevelopment of a site formerly occupied by Worcester State Hospital. Infrastructure work on the site is expected to begin this fall.
Kelleher & Sadowsky was the sole commercial real estate brokerage firm involved in the transaction. Representing the WBDC, the seller of the property, was principal James G. Umphrey and vice president Drew C. Higgins of Kelleher & Sadowsky.
The Galaxy land deal is the second transaction that Kelleher & Sadowsky has brokered at The Reactory on behalf of the WBDC in the past three months. In May, Shanghai-based WuXi Biologics purchased land at The Reactory to build its first production facility in the United States, a $60 million clinical and commercial manufacturing facility due to be operational in 2022.